Novo Nordisk $NVO rises like a phoenix from the ashes!

Since the beginning of April, the stock has gained more than 41%, and after a multi‑year slump, better times may finally be on the horizon. However, competition from $LLY remains very tough. After all, it has performed much better in recent years, and that is reflected in its stock price.

But Novo isn’t giving up, and this year it has pulled something out of its hat that $LLY has yet to beat.

In a new video, you’ll learn everything about the latest forecasts and the situation of both companies: